Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatrics
Form of B12 Deficiency Affecting the Central Nervous System May Be New Autoimmune DiseaseJuly 1, 2024Lupus & Connective Tissue Diseases
Psoriatic Arthritis Symptoms Relieved with TYK2 Inhibitor in Phase 2 TrialJune 28, 2024Psoriatic Arthritis
Psoriatic Arthritis Drug Candidate Sonelokimab Yields Significant Improvements in Phase 2 TrialJune 28, 2024Psoriatic Arthritis
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching StudiesJune 28, 2024Business of MedicineMixed Topics
Patient-Driven Care Plus Telemonitoring Yields Promising Results for SpondyloarthritisJune 28, 2024SpondyloarthropathiesAnkylosing spondylitis
‘Therapeutic Continuums’ Guide Systemic Sclerosis Treatment in Updated EULAR RecommendationsJune 26, 2024Lupus & Connective Tissue Diseases
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic ArthritisJune 26, 2024Pediatrics
